#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Loss of consciousness Iron overload Biliary neoplasm Macular telangiectasia Amyotrophic lateral sclerosis gene carrier Transitional cell carcinoma Retinal dystrophy Red blood cell abnormality Oesophageal achalasia Leiomyosarcoma metastatic Pulmonary arterial hypertension Antiphospholipid antibodies Anti-glomerular basement membrane disease Prolymphocytic leukaemia Primitive neuroectodermal tumour More trials…

    Learn about Rare Diseases

    Aicardi-Goutieres syndrome – Life with Disease Mitochondrial myopathy – Diagnostics Retinitis pigmentosa – Life with Disease Wiskott-Aldrich syndrome – Diagnostics Primary hyperoxaluria – Diagnostics Waldenstrom’s macroglobulinaemia recurrent Small intestine leiomyosarcoma – Treatment Propionic acidaemia – Life with Disease Hepatic angiosarcoma – Life with Disease Lennox-Gastaut syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cefalexin Tigulixostat Apixaban Murcidencel Agrostis Stolonifera Pollen Bisoprolol Olea Europaea Pollen Extract Enpatoran Methotrexate Sodium Elezanumab Sapablursen Ads-010 ZINC GLUCONATE RIVASTIGMINE GSKVX000000034798 Glucagon Nitrous Oxide BRENSOCATIB Propofol Bosentan More therapies…

    Learn about Your Condition

    Pustular psoriasis Appendicitis perforated B-cell lymphoma Mixed-type liposarcoma Congenital myopathy Neonatal respiratory failure Albuminuria Retinopathy of prematurity Alport's syndrome Breast cancer female Cold type haemolytic anaemia Mitral valve prolapse Ehlers-Danlos syndrome Hepatitis alcoholic Pituitary tumour benign More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic obstructive pulmonary disease

  • Study Comparing Trelegy with LABA-LAMA Drug Combination for Improving COPD Control in High-Risk Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Aclidinium Bromide
    • Fluticasone Furoate
    • Indacaterol
    Spain

  • Study on the Effects of Live Vaccines (Measles, Mumps, Rubella, BCG) on Immune System in Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Mycobacterium Bovis, Danish Strain 1331
    • Measles Virus Edmonston-Enders Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • Mumps Virus Jeryl Lynn (Level B) Strain (Live, Attenuated) Produced In Chick Embryo Cells
    Denmark

  • Study on Reducing Inhaled Corticosteroids and Using Azithromycin for Patients with Severe COPD

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Azithromycin
    Denmark

  • Study on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Benralizumab
    Austria Belgium Bulgaria Czechia Denmark Germany +7

  • Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

    Not recruiting

    3 1
    Investigated Drugs:
    • Astegolimab
    Austria Belgium Bulgaria Czechia Denmark France +10

  • Study on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    3 1
    Investigated Drugs:
    • Itepekimab
    Bulgaria Czechia Denmark Estonia France Germany +12
Previous Page
1 … 7 8 9

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!